Biomedical Sciences

© UDE/Jochen Tack

Biomedical Sciences

Biomedical research serves to improve people's health and quality of life. It aims to translate findings from basic scientific research into medical progress in the shortest possible yet qualitatively assured way.

Achievements in the field of health research have significantly contributed to double our life expectancy in the last 150 year, yet demographic change and increasing widespread diseases such as cancer, cardiovascular disease and dementia, as well as new pathogens and the health effects of environmental pollution, pose a major challenge to society.

Research under the umbrella of the main reseach area on Biomedical Sciences brings together scientists from the natural sciences and engineering faculties of the University of Duisburg-Essen with colleagues from the University Hospital Essen. The knowledge gained through interdisciplinary research should help with the understanding of the causes of widespread diseases, improve their diagnosis and identify starting points for new therapies. The collaboration of researchers from different disciplines and faculties promotes the development of innovations through cooperation and diverse, joint interdisciplinary projects.

The strategic research area is supported by two central research facilities: the Center of Medical Biotechnology (ZMB) and the Erwin L. Hahn Institute for Magnetic Resonance Imaging (ELH) on the grounds of the UNESO World Cultural Heritage Zollverein.

The ZMB links basic research in the natural sciences on the UDE campus with application-oriented medical research at the University Hospital Essen. The always flexible and also close-by local cooperation of the more than 80 interdisciplinary research groups allows to translate current basic research results directly into clinical research including the implementation of clinical studies.

At the ELH, a joint institution of the University of Duisburg-Essen, the Radboud Universiteit Nijmegen and the Ruhr-Universität Bochum, cognitive scientists, researchers from the natural and engineering sciences and physicians are dedicated to the research, further development and application of ultra-high-field magnetic resonance imaging (UHF-MRI), especially in the cognitive neurosciences and in clinical diagnostic imaging.

Scientists of this strategic research area are currently coordinating 7 joint research projects of the German Research Foundation DFG:

SFB/TRR 332: Neutrophil granulocytes: origin, fate and function

The most current Collaborative Research Centre TRR332 is a DFG-funded consortium dedicated to develop an improved understanding of neutrophil biology. Studies will reveal mechanisms of how the tissue environment regulates neutrophil production and phenotypes, how neutrophil activity is controlled intracellularly and how neutrophils function in different disease contexts. Five sub-projects are running at the UDE, spokesman in Essen is Prof. Dr. Matthias Gunzer.

Website

CRC 1430: Molecular Mechanisms on Cell State Transitions

The Collaborative Research Center 1430, established in May 2021, aims to understand how the interplay between molecular signals and the regulatory switches works, which together trigger the transitions between defined cell states. This interplay, which is as yet poorly understood, is crucial for cell growth and division, but also for the development and treatability of cancer. The researchers hope to gain new insights that will open up new treatment options.
Website

KFO 337: Phenotypic Therapy and Immune Escape in Cancer (PhenoTImE)

Since 2019, scientists in the clinical research group KFO 337 have been developing new concepts on the plasticity of malignant melanomas and tumors of the brain and pancreas. Furthermore, they investigate the development of therapy resistance and explore the underlying mechanisms. The aim is also to exchange approaches and methods and to find solid preclinical evidence for future therapy improvements.
Website

SFB/TRR 296: Local control of TH action (LocoTact)

Local mechanisms of thyroid hormone action in the target organ systems brain, heart and liver, which are the starting point of common diseases such as stroke, myocardial infarction, heart failure or liver inflammation, have been the focus of the SFB/TRR 296 since 2020. The researchers use new techniques to modulate the hormones in the human context with organoids. The aim of their investigations is to understand the disease processes in more detail and to evaluate potential therapeutic effects of targeted modulation of hormone status in local tissues.
Website

FOR 2974: Affective and cognitive mechanisms of specific Internet-use disorders (ACSID)

Since 2020 the overarching goal of the FOR 2974 research group is to understand common and distinct psychological and neurobiological processes that underlie primarily online, uncontrolled, and addictive behaviors such as computer gaming, pornography use, shopping, and social network use.
Gepris information page

SFB 1280: Extinction Learning

Since 2017, the SFB 1280 has been investigating the neural, behavioral, educational, ontogenetic and clinical mechanisms of extinction learning in different species, including humans, using different research approaches. The goal of analyzing common and distinct mechanisms of extinction learning in different systems and organisms is to establish translational insights between basic research and clinical as well as social sciences.
Website

CRC/TRR 289: Treatment Expectation

Gaining insights for a systematic application of expectancy effects in the context of medical treatments is the goal of the cross-university CRC/TRR 289. Using clinically relevant diseases such as pain disorders and affective disorders and with corresponding experimental models, the psychological and neurobiological mechanisms of positive and negative treatment expectations and their influence on pharmacological treatments are investigated.
Website

Affiliated Institutions

ZMB

The Center of Medical Biotechnology (ZMB) is an interdisciplinary scientific center of the University of Duisburg-Essen and provides the framework for research in the field of biomedical science. The ZMB integrates basic scientific research on the UDE campus with application-oriented medical research at the University Hospital Essen. The mission of the ZMB is to elucidate molecular mechanisms of disease and to turn this knowledge into medical progress. To this end, the ZMB is active in key areas of basic biomedical research, and the translation of scientific knowledge into novel drugs and diagnostic tools.

Read more

Logo Elh Ral

The Erwin L. Hahn Institute for Magnetic Resonance Imaging (ELH) is a center for research, development and application of ultra-high field magnetic resonance imaging (UHF-MRI), particularly in cognitive neurosciences and clinical diagnostic imaging.

Through close interdisciplinary and international cooperation at the ELH, technical, methodological and medical issues of the 7-Tesla UHF-MRI can be investigated comprehensively.

Read more

Board

Prof. Dr. Michael Ehrmann

Center of Medical Biotechnology (ZMB)

Phone: +49 201 183 2949
E-Mail

Website

Prof. Dr. Matthias Gunzer

Institute of Experimental Immunology & Imaging

Tel.: +49 201 183 6640
E-Mail

Website

Prof. Dr. Harald H. Quick

Erwin L. Hahn Institut (ELH)

Phone: +49 201 183 6071
E-Mail

Website

Contact

Contact ZMB

Office ZMB
University of Duisburg-Essen
Universitätsstr. 2
45141 Essen

Telefon: +49 201 183 4640
Telefax: +49 201 183 3670

E-Mail: zmb@uni-due.de

Website: https://www.uni-due.de/zmb/

Contact ELH

Office ELH
University of Duisburg-Essen
Kokereiallee 7, Gebäude C84
45141 Essen

Telefon: +49 201 183 6070
Telefax: +49 201 183 6073

E-Mail: elh@uni-due.de

Website: https://hahn-institute.de/de